Fotsing Yannick Stéphane F, Kezetas Jean Jules B, El-Saber Batiha G, Ali I and Ndjakou Bruno L: Extraction of bioactive compounds from medicinal plants and herbs. In: El-Shemy HA (ed). Natural Medicinal Plants. IntechOpen; London, UK, 2022.

Balekundri A and Mannur V: Quality control of the traditional herbs and herbal products: A review. Futur J Pharm Sci. 6(67)2020.

Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P and Gallelli L: Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation. Molecules. 25(63)2019.PubMed/NCBI View Article : Google Scholar

Lambert JD, Lee MJ, Lu H, Meng X, Hong JJ, Seril DN, Sturgill MG and Yang CS: Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr. 133:4172–4177. 2003.PubMed/NCBI View Article : Google Scholar

Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D, Bhayye S, Dubey R, Singh HN and Kumar S: Anticancer Drug discovery based on natural products: From computational approaches to clinical studies. Biomedicines. 12(201)2024.PubMed/NCBI View Article : Google Scholar

Pandey AK, Gulati S, Gupta A and Tripathi YC: Variation in andrographolide content among different accessions of Andrographis paniculata. Pharma Innov J. 8:140–144. 2019.

Liang D, Zhang WM, Liang X, Tian HY, Zhang XM, Li X and Gao WY: A review on the extraction and separation of andrographolide from Andrographis paniculata: Extraction selectivity, current challenges and strategies. Tradit Med Res. 8(38)2023.

Sharma S, Sharma YP and Bhardwaj C: HPLC quantification of andrographolide in different parts of Andrographis paniculata (Burm.f.) Wall. ex Nees. J Pharmacogn Phytochem. 7:168–171. 2018.

Kandanur SGS, Tamang N, Golakoti NR and Nanduri S: Andrographolide: A natural product template for the generation of structurally and biologically diverse diterpenes. Eur J Med Chem. 176:513–533. 2019.PubMed/NCBI View Article : Google Scholar

Tran QTN, Tan WSD, Wong WSF and Chai CLL: Polypharmacology of andrographolide: Beyond one molecule one target. Nat Prod Rep. 38:682–692. 2021.PubMed/NCBI View Article : Google Scholar

Phunikom N, Boonmuen N, Kheolamai P, Suksen K, Manochantr S, Tantrawatpan C and Tantikanlayaporn D: Andrographolide promotes proliferative and osteogenic potentials of human placenta-derived mesenchymal stem cells through the activation of Wnt/β-catenin signaling. Stem Cell Res Ther. 12(241)2021.PubMed/NCBI View Article : Google Scholar

Nair DS and Manjula S: Induction of root endosymbiosis as a highly sustainable and efficient strategy for overproduction of the medicinally important diterpenoid lactone-andrographolide in Andrographis paniculata (Burm. F.) Wall. ex Nees. Ind Crops Prod. 156(112835)2020.

Dai Y, Chen SR, Chai L, Zhao J and Wang Y and Wang Y: Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr. 59 (Suppl 1):S17–S29. 2019.PubMed/NCBI View Article : Google Scholar

Tundis R, Patra JK, Bonesi M, Das S, Nath R, Das Talukdar A, Das G and Loizzo MR: Anti-cancer agent: The labdane diterpenoid-andrographolide. Plants (Basel). 12(1969)2023.PubMed/NCBI View Article : Google Scholar

Cai W, Li J, Chen C, Wu J, Li J and Xue X: Design, synthesis, and anticancer evaluation of novel andrographolide derivatives bearing an α,β-unsaturated ketone moiety. Bioorg Chem. 112(104941)2021.PubMed/NCBI View Article : Google Scholar

Arsakhant P, Sirion U, Chairoungdua A, Suksen K, Piyachaturawat P, Suksamrarn A and Saeeng R: Design and synthesis of C-12 dithiocarbamate andrographolide analogues as an anticancer agent. Bioorg Med Chem Lett. 30(127263)2020.PubMed/NCBI View Article : Google Scholar

Cheng CR, Zheng Z, Liang RM, Li XF, Jiang QQ, Yue L, Wang Q, Ding J and Liu Y: Preparation and cytotoxic Activity of 3,19-analogues of 12-thioether andrographolide. Chem Nat Compd. 56:264–269. 2020.

Beesetti SL, Jayadev M, Subhashini GV, Mansour L, Alwasel S and Harrath AH: Andrographolide as a therapeutic agent against breast and ovarian cancers. Open Life Sci. 14:462–469. 2019.PubMed/NCBI View Article : Google Scholar

He X, Li J, Gao H, Qiu F, Hu K, Cui X and Yao X: Identification of a rare sulfonic acid metabolite of andrographolide in rats. Drug Metab Dispos. 31:983–985. 2003.PubMed/NCBI View Article : Google Scholar

Sa-ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha J, et al: Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 84:1261–1270. 2021.PubMed/NCBI View Article : Google Scholar

Banerjee M, Parai D, Chattopadhyay S and Mukherjee SK: Andrographolide: Antibacterial activity against common bacteria of human health concern and possible mechanism of action. Folia Microbiol (Praha). 62:237–244. 2017.PubMed/NCBI View Article : Google Scholar

Widyawaruyanti A, Asrory M, Ekasari W, Setiawan D, Radjaram A, Tumewu L and Hafid AF: In vivo antimalarial activity of Andrographis paniculata tablets. Procedia Chem. 13:101–104. 2014.

Yu Q, Shi Y, Shu C, Ding X, Zhu S, Shen Z and Lou Y: Andrographolide inhibition of Th17-regulated cytokines and JAK1/STAT3 signaling in OVA-stimulated asthma in mice. Evid Based Complement Alternat Med. 2021(6862073)2021.PubMed/NCBI View Article : Google Scholar

Astuti NT, Novitasari PR, Tjandrawinata R, Nugroho AE and Pramono S: Anti-diabetic effect of andrographolide from Sambiloto herbs (Andrographis paniculata (Burm.f.) Nees) through the expression of PPARγ and GLUT-4 in adipocytes. Indones J Biotechnol. 27(203)2022.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar

Gadi VK and Davidson NE: Practical approach to triple-negative breast cancer. J Oncol Pract. 13:293–300. 2017.PubMed/NCBI View Article : Google Scholar

Li L, Yang LL, Yang SL, Wang RQ, Gao H, Lin ZY, Zhao YY, Tang WW, Han R, Wang WJ, et al: Andrographolide suppresses breast cancer progression by modulating tumor-associated macrophage polarization through the Wnt/β-catenin pathway. Phyther Res. 36:4587–4603. 2022.PubMed/NCBI View Article : Google Scholar

Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, et al: Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10:1367–1401. 2022.PubMed/NCBI View Article : Google Scholar

Aggarwal S, Verma SS, Aggarwal S and Gupta SC: Drug repurposing for breast cancer therapy: Old weapon for new battle. Semin Cancer Biol. 68:8–20. 2021.PubMed/NCBI View Article : Google Scholar

Hung Y, Leung S, Chiu SP, Li PY, Kan AC, Lo CC, Wong SZ, Luk SL, Lai CC, El Helali A and Chan WW: Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study. Cancer Med. 12:1997–2007. 2023.PubMed/NCBI View Article : Google Scholar

Cohen I, Tagliaferri M and Tripathy D: Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 29:563–574. 2002.PubMed/NCBI View Article : Google Scholar

Wang R, Wang Y, Fang L, Xie Y, Yang S, Liu S, Fang Y and Zhang Y: Efficacy and safety of traditional Chinese medicine in the treatment of menopause-like syndrome for breast cancer survivors: A systematic review and meta-analysis. BMC Cancer. 24(42)2024.PubMed/NCBI View Article : Google Scholar

Shu J, Huang R, Tian Y, Liu Y, Zhu R and Shi G: Andrographolide protects against endothelial dysfunction and inflammatory response in rats with coronary heart disease by regulating PPAR and NF-κB signaling pathways. Ann Palliat Med. 9:1965–1975. 2020.PubMed/NCBI View Article : Google Scholar

Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, et al: Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 173:4207–4217. 2004.PubMed/NCBI View Article : Google Scholar

Li Z and Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP and Wu JC: Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 116 (11 Suppl):I46–I54. 2007.PubMed/NCBI View Article : Google Scholar

Giordano SH: Breast cancer in men. N Engl J Med. 378:2311–2320. 2018.PubMed/NCBI View Article : Google Scholar

Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, Mönkkönen J, Kellokumpu-Lehtinen PL, Lauttia S, Tynninen O, Joensuu H, et al: Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res. 17(101)2015.PubMed/NCBI View Article : Google Scholar

Yang Q, Guo N, Zhou Y, Chen J, Wei Q and Han M: The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B. 10:2156–2170. 2020.PubMed/NCBI View Article : Google Scholar

Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC and Balkwill FR: ‘Re-educating’ tumor-associated macrophages by targeting NF-κB. J Exp Med. 205:1261–1268. 2008.PubMed/NCBI View Article : Google Scholar

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020.PubMed/NCBI View Article : Google Scholar

Ohri A, Robinson A, Liu B, Bhuket T and Wong R: Updated assessment of colorectal cancer incidence in the U.S. by age, sex, and race/ethnicity. Dig Dis Sci. 65:1838–1849. 2020.PubMed/NCBI View Article : Google Scholar

Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V and Namdar A: Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 234:17127–17143. 2019.PubMed/NCBI View Article : Google Scholar

Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, et al: Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: A United States population-based study. Gastroenterology. 150:1135–1146. 2016.PubMed/NCBI View Article : Google Scholar

Xynos ID, Kavantzas N, Tsaousi S, Zacharakis M, Agrogiannis G, Kosmas C, Lazaris A, Sarantonis J, Sougioultzis S, Tzivras D, et al: Factors influencing survival in stage IV colorectal cancer: The influence of DNA ploidy. ISRN Gastroenterol. 2013(490578)2013.PubMed/NCBI View Article : Google Scholar

Xie YH, Chen YX and Fang JY: Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 5(22)2020.PubMed/NCBI View Article : Google Scholar

García-Alfonso P, Muñoz Martín AJ, Ortega Morán L, Soto Alsar J, Torres Pérez-Solero G, Blanco Codesido M, Calvo Ferrandiz PA and Grasso Cicala S: Oral drugs in the treatment of metastatic colorectal cancer. Ther Adv Med Oncol. 13(17588359211009001)2021.PubMed/NCBI View Article : Google Scholar

Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, et al: ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 27:1386–1422. 2016.PubMed/NCBI View Article : Google Scholar

Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, et al: Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics. 9:1923–1951. 2019.PubMed/NCBI View Article : Google Scholar

Palmieri A, Scapoli L, Iapichino A, Mercolini L, Mandrone M, Poli F, Giannì AB, Baserga C and Martinelli M: Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways. Int J Immunopathol Pharmacol. 33(2058738419855567)2019.PubMed/NCBI View Article : Google Scholar

Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, Das H, Srivastava S, Prasad S and Srivastava SK: Role of phytochemicals in cancer prevention. Int J Mol Sci. 20(4981)2019.PubMed/NCBI View Article : Google Scholar

Islam MT, Ali ES, Uddin SJ, Islam MA, Shaw S, Khan IN, Saravi SSS, Ahmad S, Rehman S, Gupta VK, et al: Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett. 420:129–145. 2018.PubMed/NCBI View Article : Google Scholar

Shi MD, Lin HH, Lee YC, Chao JK, Lin RA and Chen JH: Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact. 174:201–210. 2008.PubMed/NCBI View Article : Google Scholar

Norouzi M and Hardy P: Clinical applications of nanomedicines in lung cancer treatment. Acta Biomater. 121:134–142. 2021.PubMed/NCBI View Article : Google Scholar

Torre LA, Siegel RL and Jemal A: Lung cancer statistics. Adv Exp Med Biol. 893:1–19. 2016.PubMed/NCBI View Article : Google Scholar

Thandra KC and Barsouk A, Saginala K, Aluru JS and Barsouk A: Epidemiology of lung cancer. Contemp Oncol (Pozn). 25:45–52. 2021.PubMed/NCBI View Article : Google Scholar

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar

Commar A, Prasad V and D'Espaignet ET: WHO global report on trends in prevalence of tobacco use 2000-2025, 2021. https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition.

Dougherty SM, Mazhawidza W, Bohn AR, Robinson KA, Mattingly KA, Blankenship KA, Huff MO, McGregor WG and Klinge CM: Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer. 13:113–134. 2006.PubMed/NCBI View Article : Google Scholar

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar

Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, et al: A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 85:679–691. 2009.PubMed/NCBI View Article : Google Scholar

Yokota J, Shiraishi K and Kohno T: Genetic basis for susceptibility to lung cancer: Recent progress and future directions. Adv Cancer Res. 109:51–72. 2010.PubMed/NCBI View Article : Google Scholar

Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 452:638–642. 2008.PubMed/NCBI View Article : Google Scholar

Hussain S: Nanomedicine for treatment of lung cancer. In: Ahmad A, Gadgeel S (eds). Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Advances in Experimental Medicine and Biology. Vol. 890. Springer, Cham, pp137-147, 2016.

Sun A, Durocher-Allen LD, Ellis PM, Ung YC, Goffin JR, Ramchandar K and Darling G: Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: A systematic review. Curr Oncol. 26:e372–e384. 2019.PubMed/NCBI View Article : Google Scholar

Bahman F, Elkaissi S, Greish K and Taurin S: Polymeric micelles in management of lung cancer. In: Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Elsevier, pp193-216, 2019.

Norouzi M, Amerian M, Amerian M and Atyabi F: Clinical applications of nanomedicine in cancer therapy. Drug Discov Today. 25:107–125. 2020.PubMed/NCBI View Article : Google Scholar

Norouzi M, Yathindranath V, Thliveris JA and Miller DW: Salinomycin-loaded iron oxide nanoparticles for glioblastoma therapy. Nanomaterials (Basel). 10(477)2020.PubMed/NCBI View Article : Google Scholar

Ricciardi S, Tomao S and de Marinis F: Toxicity of targeted therapy in non-small-cell lung cancer management. Clin Lung Cancer. 10:28–35. 2009.PubMed/NCBI View Article : Google Scholar

Su XL, Wang JW, Che H, Wang CF, Jiang H, Lei X, Zhao W, Kuang HX and Wang QH: Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chin Med J (Engl). 133:2987–2997. 2020.PubMed/NCBI View Article : Google Scholar

Paul S, Roy D, Pati S and Sa G: The adroitness of andrographolide as a natural weapon against colorectal cancer. Front Pharmacol. 12(731492)2021.PubMed/NCBI View Article : Google Scholar

Lin HH, Tsai CW, Chou FP, Wang CJ, Hsuan SW, Wang CK and Chen JH: Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Toxicol Appl Pharmacol. 250:336–345. 2011.PubMed/NCBI View Article : Google Scholar

Jiaqi L, Siqing H, qin W, di Z, bei Z and jialin Y: Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction. Phytomedicine. 109(154601)2023.PubMed/NCBI View Article : Google Scholar

Neamatallah T, Malebari AM, Alamoudi AJ, Nazreen S, Alam MM, Bin-Melaih HH, Abuzinadah OA, Badr-Eldin SM, Alhassani G, Makki L and Nasrullah MZ: Andrographolide nanophytosomes exhibit enhanced cellular delivery and pro-apoptotic activities in HepG2 liver cancer cells. Drug Deliv. 30(2174209)2023.PubMed/NCBI View Article : Google Scholar

Shannon AH, Ruff SM and Pawlik TM: Expert insights on current treatments for hepatocellular carcinoma: Clinical and molecular approaches and bottlenecks to progress. J Hepatocell Carcinoma. 9:1247–1261. 2022.PubMed/NCBI View Article : Google Scholar

Rimassa L and Gish GR: HCC in focus: Current developments in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y). 14:542–544. 2018.

Xi SY and Minuk GY: Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol. 10:799–806. 2018.PubMed/NCBI View Article : Google Scholar

Siegel RL, Giaquinto AN and Jemal A: Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.PubMed/NCBI View Article : Google Scholar

Forestier-Román IS, López-Rivas A, Sánchez-Vázquez MM, Rohena-Rivera K, Nieves-Burgos G, Ortiz-Zuazaga H, Torres-Ramos CA and Martínez-Ferrer M: Andrographolide induces DNA damage in prostate cancer cells. Oncotarget. 10:1085–1101. 2019.PubMed/NCBI View Article : Google Scholar

Chen FZ and Zhao XK: Prostate cancer: Current treatment and prevention strategies. Iran Red Crescent Med J. 15:279–284. 2013.PubMed/NCBI View Article : Google Scholar

Malinowski B, Wiciński M, Musiała N, Osowska I and Szostak M: Previous, current, and future pharmacotherapy and diagnosis of prostate cancer-a comprehensive review. Diagnostics (Basel). 9(161)2019.PubMed/NCBI View Article : Google Scholar

Jiang J, Slivova V, Valachovicova T, Harvey K and Sliva D: Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 24:1093–1099. 2004.PubMed/NCBI

Chun JY, Tummala R, Nadiminty N, Lou W, Liu C, Yang J, Evans CP, Zhou Q and Gao AC: Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer. 1:868–876. 2010.PubMed/NCBI View Article : Google Scholar

Munir AH and Khan MI: Pattern of basic hematological parameters in acute and chronic leukemias. J Med Sci. 27:125–129. 2019.

Li X, Wu T, Chen W, Zhang J, Jiang Y, Deng J, Long W, Qin X and Zhou Y: Andrographolide acts with dexamethasone to inhibit the growth of acute lymphoblastic leukemia CEM-C1 cells via the regulation of the autophagy-dependent PI3K/AKT/mTOR signaling pathway. Biomed Reports. 20(43)2024.PubMed/NCBI View Article : Google Scholar

Hunger SP and Mullighan CG: Acute lymphoblastic leukemia in children. N Engl J Med. 373:1541–1552. 2015.PubMed/NCBI View Article : Google Scholar

Samii B, Jafarian A, Rabbani M, Zolfaghari B, Rahgozar S and Pouraboutaleb E: The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia. Res Pharm Sci. 18:381–391. 2023.PubMed/NCBI View Article : Google Scholar

Follini E, Marchesini M and Roti G: Strategies to overcome resistance mechanisms in T-cell acute lymphoblastic leukemia. Int J Mol Sci. 20(3021)2019.PubMed/NCBI View Article : Google Scholar

Wang YJ, Liao CC, Chen HJ, Hsieh CL and Li TC: The effectiveness of traditional Chinese medicine in treating patients with leukemia. Evid Based Complement Alternat Med. 2016(8394850)2016.PubMed/NCBI View Article : Google Scholar

Yang T, Yao S, Zhang X and Guo Y: Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways. Drug Des Devel Ther. 10:1389–1397. 2016.PubMed/NCBI View Article : Google Scholar

Cai Q, Zhang W, Sun Y, Xu L, Wang M, Wang X, Wang S and Ni Z: Study on the mechanism of andrographolide activation. Front Neurosci. 16(977376)2022.PubMed/NCBI View Article : Google Scholar

Li X, Yuan W, Wu J, Zhen J, Sun Q and Yu M: Andrographolide, a natural anti-inflammatory agent: An update. Front Pharmacol. 13(920435)2022.PubMed/NCBI View Article : Google Scholar

Harrington BS and Annunziata CM: NF-κB signaling in ovarian cancer. Cancers (Basel). 11(1182)2019.PubMed/NCBI View Article : Google Scholar

Khan H, Ullah H, Castilho PCMF, Gomila AS, D'Onofrio G, Filosa R, Wang F, Nabavi SM, Daglia M, Silva AS, et al: Targeting NF-κB signaling pathway in cancer by dietary polyphenols. Crit Rev Food Sci Nutr. 60:2790–2800. 2020.PubMed/NCBI View Article : Google Scholar

Yu H and Jove R: The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.PubMed/NCBI View Article : Google Scholar

Vivanco I and Sawyers CL: The phosphatidylinositol 3-Kinase-AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002.PubMed/NCBI View Article : Google Scholar

Baldwin AS Jr: Series introduction: The transcription factor NF-kappaB and human disease. J Clin Invest. 107:3–6. 2001.PubMed/NCBI View Article : Google Scholar

Showalter A, Limaye A, Oyer JL, Igarashi R, Kittipatarin C, Copik AJ and Khaled AR: Cytokines in immunogenic cell death: Applications for cancer immunotherapy. Cytokine. 97:123–132. 2017.PubMed/NCBI View Article : Google Scholar

Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A, Seyed Saleh SH, Bagherian M, Sharifzadeh SO, Hushmandi K, et al: Regulation of nuclear factor-kappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? Cancer Lett. 509:63–80. 2021.PubMed/NCBI View Article : Google Scholar

Singh V, Gupta D and Arora R: NF-kB as a key player in regulation of cellular radiation responses and identification of radiation countermeasures. Discoveries (Craiova). 3(e35)2015.PubMed/NCBI View Article : Google Scholar

Sun SC: The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 17:545–558. 2017.PubMed/NCBI View Article : Google Scholar

Kawai T and Akira S: The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol. 11:373–384. 2010.PubMed/NCBI View Article : Google Scholar

Lin L, Hu X, Zhang H and Hu H: Tertiary lymphoid organs in cancer immunology: Mechanisms and the new strategy for immunotherapy. Front Immunol. 10(1398)2019.PubMed/NCBI View Article : Google Scholar

Abramson J and Anderson G: Thymic epithelial cells. Annu Rev Immunol. 35:85–118. 2017.PubMed/NCBI View Article : Google Scholar

Serasanambati M and Chilakapati SR: Function of nuclear factor kappa B (NF-kB) in human diseases-a review. South Indian J Biol Sci. 2(368)2016.

Ben Hamouda S and Essafi-Benkhadir K: Interplay between signaling pathways and tumor microenvironment components: A paradoxical role in colorectal cancer. Int J Mol Sci. 24(5600)2023.PubMed/NCBI View Article : Google Scholar

Sun SC: Non-canonical NF-κB signaling pathway. Cell Res. 21:71–85. 2011.PubMed/NCBI View Article : Google Scholar

Jost PJ and Ruland J: Aberrant NF-kappaB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications. Blood. 109:2700–2707. 2007.PubMed/NCBI View Article : Google Scholar

Zhang T, Ma C, Zhang Z, Zhang H and Hu H: NF-κB signaling in inflammation and cancer. MedComm (2020). 2:618–653. 2021.PubMed/NCBI View Article : Google Scholar

Liu T, Zhang L, Joo D and Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther. 2(17023)2017.PubMed/NCBI View Article : Google Scholar

Oeckinghaus A and Ghosh S: The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 1(a000034)2009.PubMed/NCBI View Article : Google Scholar

Guan C, Zhou X, Li H, Ma X and Zhuang J: NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds. Biomed Pharmacother. 156(113951)2022.PubMed/NCBI View Article : Google Scholar

Zhang R, Zhao J, Xu J, Jiao DX, Wang J, Gong ZQ and Jia JH: Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway. Oncol Lett. 14:4305–4310. 2017.PubMed/NCBI View Article : Google Scholar

Im NK, Jang WJ, Jeong CH and Jeong GS: Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-κB activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells. J Med Food. 17:855–861. 2014.PubMed/NCBI View Article : Google Scholar

Liu MY, Li HJ, Yang C, Zang WD, Liu ZD, Zhang L, Li PH, Zhu YJ, Zhao YY, Liu RZ and Gao YZ: Insight into the pharmacological effects of andrographolide in musculoskeletal disorders. Biomed Pharmacother. 146(112583)2022.PubMed/NCBI View Article : Google Scholar

Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, Chorzalska A and Dubielecka PM: NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Commun Signal. 21(291)2023.PubMed/NCBI View Article : Google Scholar

Naserian S, Abdelgawad ME, Afshar Bakshloo M, Ha G, Arouche N, Cohen JL, Salomon BL and Uzan G: The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect. Cell Commun Signal. 18(94)2020.PubMed/NCBI View Article : Google Scholar

Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12(86)2013.PubMed/NCBI View Article : Google Scholar

Li Y, He S, Tang J, Ding N, Chu X, Cheng L, Ding X, Liang T, Feng S, Rahman SU, et al: Andrographolide inhibits inflammatory cytokines secretion in LPS-stimulated RAW264.7 cells through suppression of NF-κB/MAPK signaling pathway. Evid Based Complement Alternat Med. 2017(8248142)2017.PubMed/NCBI View Article : Google Scholar

Li J, Huang L, He Z, Chen M, Ding Y, Yao Y, Duan Y, Zixuan L, Qi C, Zheng L, et al: Andrographolide suppresses the growth and metastasis of luminal-like breast cancer by inhibiting the NF-κB/miR-21-5p/PDCD4 signaling pathway. Front Cell Dev Biol. 9(643525)2021.PubMed/NCBI View Article : Google Scholar

Zou W, Xiao Z, Wen X, Luo J, Chen S, Cheng Z, Xiang D, Hu J and He J: The anti-inflammatory effect of Andrographis paniculata (Burm. f.) Nees on pelvic inflammatory disease in rats through down-regulation of the NF-κB pathway. BMC Complement Altern Med. 16(483)2016.PubMed/NCBI View Article : Google Scholar

Wang W, Mani AM and Wu ZH: DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression. J Cancer Metastasis Treat. 3:45–59. 2017.PubMed/NCBI View Article : Google Scholar

Han S, Huang T, Li W, Liu S, Yang W, Shi Q, Li H, Ren J and Hou F: Association between hypoxia-inducible factor-2α (HIF-2α) expression and colorectal cancer and its prognostic role: A systematic analysis. Cell Physiol Biochem. 48:516–527. 2018.PubMed/NCBI View Article : Google Scholar

Masoud GN and Li W: HIF-1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015.PubMed/NCBI View Article : Google Scholar

Walsh JC, Lebedev A, Aten E, Madsen K, Marciano L and Kolb HC: The clinical importance of assessing tumor hypoxia: Relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxidants Redox Signal. 21:1516–1554. 2014.PubMed/NCBI View Article : Google Scholar

Cerychova R and Pavlinkova G: HIF-1, metabolism, and diabetes in the embryonic and adult heart. Front Endocrinol (Lausanne). 9(460)2018.PubMed/NCBI View Article : Google Scholar

Glaus Garzon JF, Pastrello C, Jurisica I, Hottiger MO, Wenger RH and Borsig L: Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development. Neoplasia. 22:745–758. 2020.PubMed/NCBI View Article : Google Scholar

Carmeliet P and Jain RK: Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10:417–427. 2011.PubMed/NCBI View Article : Google Scholar

Li J, Zhang C, Jiang H and Cheng J: Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. Onco Targets Ther. 8:427–435. 2015.PubMed/NCBI View Article : Google Scholar

Kubaichuk K and Kietzmann T: USP10 contributes to colon carcinogenesis via mTOR/S6K mediated HIF-1α but Not HIF-2α protein synthesis. Cells. 12(1585)2023.PubMed/NCBI View Article : Google Scholar

Shi L, Zhang G, Zheng Z, Lu B and Ji L: Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA. Chem Biol Interact. 273:228–236. 2017.PubMed/NCBI View Article : Google Scholar

Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley CR and Bishayee A: Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells. 9(1451)2020.PubMed/NCBI View Article : Google Scholar

Firdous P, Nissar K, Sabba A, Hassan T and Maqbool MT: Application of plasma membrane proteomics to identify cancer biomarkers. In: Ali S, Majid S and Rehman MU (eds). Proteomics: A Promising Approach for Cancer Research. Elsevier, pp287-317, 2023.

Hu Q, Bian Q, Rong D, Wang L, Song J, Huang HS, Zeng J, Mei J and Wang PY: JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 11(1110765)2023.PubMed/NCBI View Article : Google Scholar

Huang B, Lang X and Li X: The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. 12(1023177)2022.PubMed/NCBI View Article : Google Scholar

Bao GQ, Shen BY, Pan CP, Zhang YJ, Shi MM and Peng CH: Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer. Toxicol Lett. 222:23–35. 2013.PubMed/NCBI View Article : Google Scholar

Wang XR, Jiang ZB, Xu C, Meng WY, Liu P, Zhang YZ, Xie C, Xu JY, Xie YJ, Liang TL, et al: Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response. Pharmacol Res. 179(106198)2022.PubMed/NCBI View Article : Google Scholar

Zhou J, Ong CN, Hur GM and Shen HM: Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. Biochem Pharmacol. 79:1242–1250. 2010.PubMed/NCBI View Article : Google Scholar

Chen SR, Li F, Ding MY, Wang D, Zhao Q and Wang Y, Zhou GC and Wang Y: Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice. Bioorg Med Chem. 26:5053–5061. 2018.PubMed/NCBI View Article : Google Scholar

Bousoik E and Montazeri Aliabadi H: ‘Do we know Jack’ About JAK? A closer look at JAK/STAT signaling pathway. Front Oncol. 8(287)2018.PubMed/NCBI View Article : Google Scholar

Lemmon MA and Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.PubMed/NCBI View Article : Google Scholar

Su YC, Lee WC, Wang CC, Yeh SA, Chen WH and Chen PJ: Targeting PI3K/AKT/mTOR signaling pathway as a radiosensitization in head and neck squamous cell carcinomas. Int J Mol Sci. 23(15749)2022.PubMed/NCBI View Article : Google Scholar

Tohkayomatee R, Reabroi S, Tungmunnithum D, Parichatikanond W and Pinthong D: Andrographolide exhibits anticancer activity against breast cancer cells (MCF-7 and MDA-MB-231 cells) through suppressing cell proliferation and inducing cell apoptosis via inactivation of ER-α receptor and PI3K/AKT/mTOR signaling. Molecules. 27(3544)2022.PubMed/NCBI View Article : Google Scholar

Weerackoon N, Gunawardhana KL and Mani A: Wnt signaling cascades and their role in coronary artery health and disease. J Cell Signal. 2:52–62. 2021.PubMed/NCBI View Article : Google Scholar

Reyes M, Flores T, Betancur D, Peña-Oyarzún D and Torres VA: Wnt/β-catenin signaling in oral carcinogenesis. Int J Mol Sci. 21(4682)2020.PubMed/NCBI View Article : Google Scholar

MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009.PubMed/NCBI View Article : Google Scholar

MacDonald BT and He X: Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect Biol. 4(a007880)2012.PubMed/NCBI View Article : Google Scholar

Steinhart Z and Angers S: Wnt signaling in development and tissue homeostasis. Development. 145(dev146589)2018.PubMed/NCBI View Article : Google Scholar

Chatterjee A, Paul S, Bisht B, Bhattacharya S, Sivasubramaniam S and Paul MK: Advances in targeting the WNT/β-catenin signaling pathway in cancer. Drug Discov Today. 27:82–101. 2022.PubMed/NCBI View Article : Google Scholar

Jackstadt R, Hodder MC and Sansom OJ: WNT and β-catenin in cancer: Genes and therapy. Annu Rev Cancer Biol. 4:177–196. 2020.

Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G and Yin G: Wnt/β-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 7(3)2022.PubMed/NCBI View Article : Google Scholar

Cruciat CM and Niehrs C: Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb Perspect Biol. 5(a015081)2013.PubMed/NCBI View Article : Google Scholar

Skronska-Wasek W, Mutze K, Baarsma HA, Bracke KR, Alsafadi HN, Lehmann M, Costa R, Stornaiuolo M, Novellino E, Brusselle GG, et al: Reduced frizzled receptor 4 expression prevents WNT/β-catenin-driven alveolar lung repair in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 196:172–185. 2017.PubMed/NCBI View Article : Google Scholar

Sharma P, Shimura T, Banwait JK and Goel A: Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer. Carcinogenesis. 41:1385–1394. 2020.PubMed/NCBI View Article : Google Scholar

Rubinfeld H and Seger R: The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol. 31:151–174. 2005.PubMed/NCBI View Article : Google Scholar

Karnoub AE and Weinberg RA: Ras oncogenes: Split personalities. Nat Rev Mol Cell Biol. 9:517–531. 2008.PubMed/NCBI View Article : Google Scholar

Zlobin A, Bloodworth JC and Osipo C: Mitogen-activated protein kinase (MAPK) signaling. In: Badve S, Kumar G (eds). Predictive Biomarkers in Oncology. Springer, Cham, pp213-221, 2019.

Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y and Hu LL: ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 19:1997–2007. 2020.PubMed/NCBI View Article : Google Scholar

Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290. 2007.PubMed/NCBI View Article : Google Scholar

Ballestín A, Armocida D, Ribecco V and Seano G: Peritumoral brain zone in glioblastoma: Biological, clinical and mechanical features. Front Immunol. 15(1347877)2024.PubMed/NCBI View Article : Google Scholar

Yang SL, Kuo FH, Chen PN, Hsieh YH, Yu NY, Yang WE, Hsieh MJ and Yang SF: Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression. Oncotarget. 8:105860–105872. 2017.PubMed/NCBI View Article : Google Scholar

Zhang C, Yang C, Feldman MJ, Wang H, Pang Y, Maggio DM, Zhu D, Nesvick CL, Dmitriev P, Bullova P, et al: Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha. Oncotarget. 8:56110–56125. 2017.PubMed/NCBI View Article : Google Scholar